文献速递系统性红斑狼疮

系统性红斑狼疮患者B细胞谱系表观遗传缺陷的人群特异性模式

Population-Specific Patterns of Epigenetic Defects in the B Cell Lineage in Patients With Systemic Lupus Erythematosus.
PubMed 文献 · Arthritis Rheumatol · 2019-12-26

研究在非洲裔美国(AA)和欧洲裔美国(EA)SLE患者中,确定SLE相关DNA甲基化特征在B细胞发育的哪个阶段起源,并评估B细胞发育模式中的表观遗传缺陷能否预测个体及混合免疫细胞群中的SLE状态。结果显示SLE特异性甲基化模式具有种族依赖性,AA女性患者B细胞发育早期干扰素调节基因附近的表观遗传改变是SLE的标志,EBF1结合位点高度富集显著甲基化变化。

要点

  • SLE相关DNA甲基化特征在B细胞发育早期即出现,且模式因种族而异。
  • AA患者SLE相关低甲基化位点富集干扰素调节基因和EBF1结合。
  • 过渡B细胞亚群构建的表观遗传模型可高精度区分AA患者与健康对照。

核心结论

  • SLE特异性甲基化模式具有种族依赖性,AA女性患者B细胞发育早期干扰素调节基因附近的表观遗传改变是SLE标志。
  • EBF1结合位点高度富集显著甲基化变化,提示其可能是SLE相关表观遗传变化的潜在调节因子。

研究设计与样本

  • 研究纳入AA患者(n=31)和EA患者(n=49),包括有或无SLE者,用流式细胞分选将B细胞分为5个亚群。
  • 在约460,000个CpG位点检测每个亚群的DNA甲基化,并进行SLE相关甲基化位点的转录因子相互作用富集分析。
  • 使用随机森林算法在B细胞亚群中识别SLE表观遗传特征,并在独立AA和EA患者及健康对照队列中验证。

主要发现

  • 跨所有B细胞阶段的回归分析识别出60个CpG达到全基因组显著性水平的SLE相关甲基化差异(P ≤ 1.07 × 10-7)。
  • AA患者中SLE相关种族特异性CpG呈现低甲基化模式,富集干扰素调节基因和EBF1结合(各P < 0.001)。
  • 用过渡B细胞亚群开发的预测模型应用于其他B细胞亚群时,区分AA SLE患者与健康对照的平均ROC AUC为0.98。
  • 在独立验证队列中,该模型应用于CD19+泛B细胞时平均ROC AUC为0.95,应用于CD4+泛T细胞时平均ROC AUC为0.97。

临床怎么用

  • 在AA女性SLE患者中,B细胞发育早期干扰素调节基因附近的甲基化改变可作为潜在表观遗传标志。
  • 基于过渡B细胞亚群构建的表观遗传特征模型或有助于区分AA患者SLE状态,但需进一步验证。

局限性

  • 研究未报告样本量以外的其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the stage of B cell development at which a systemic lupus erythematosus (SLE)-associated DNA methylation signature originates in African American (AA) and European American (EA) subjects, and to assess whether epigenetic defects in B cell development patterns could be predictive of SLE status in individual and mixed immune cell populations. METHODS: B cells from AA patients (n = 31) and EA patients (n = 49) with or without SLE were sorted using fluorescence-activated cell sorting into 5 B cell subsets. DNA methylation, measured at ~460,000 CpG sites, was interrogated in each subset. Enrichment analysis of transcription factor interaction at SLE-associated methylation sites was performed. A random forests algorithm was used to identify an epigenetic signature of SLE in the B cell subsets, which was then validated in an independent cohort of AA and EA patients and healthy controls. RESULTS: Regression analysis across all B cell stages resulted in identification of 60 CpGs that reached genome-wide significance for SLE-associated methylation differences (P ≤ 1.07 × 10-7 ). Interrogation of ethnicity-specific CpGs associated with SLE revealed a hypomethylated pattern that was enriched for interferon (IFN)-regulated genes and binding of EBF1 in AA patients (each P < 0.001). AA patients with SLE could be distinguished from healthy controls when the predictive model developed with the transitional B cell subset was applied to other B cell subsets (mean receiver operating characteristic [ROC] area under the curve [AUC] 0.98), and when applied to CD19+ pan-B cells (mean ROC AUC 0.95) and CD4+ pan-T cells (mean ROC AUC 0.97) from the independent validation cohort. CONCLUSION: These results indicate that SLE-specific methylation patterns are ethnicity dependent. A pattern of epigenetic changes near IFN-regulated genes early in B cell development is a hallmark of SLE in AA female subjects. EBF1 binding sites are highly enriched for significant methylation changes, implying that this may be a potential regulator of SLE-associated epigenetic changes.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Breitbach ME, Ramaker RC, Roberts K, et al. Population-Specific Patterns of Epigenetic Defects in the B Cell Lineage in Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019. PMID: 31430064. doi:10.1002/art.41083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。